Download PDF

1. Company Snapshot

1.a. Company Description

Akso Health Group operates a social e-commerce mobile platform in China.The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc.It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products.


The company was formerly known as Xiaobai Maimai Inc.and changed its name to Akso Health Group in December 2021.Akso Health Group was founded in 2014 and is headquartered in Beijing, China.


As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.

Show Full description

1.b. Last Insights on AHG

Akso Health Group's recent performance was hindered by a lack of concrete financial results, with the company's most recent earnings release not providing a clear picture of its current financial health. The absence of a recent earnings release suggests that the company may be prioritizing strategic initiatives over short-term financial reporting. Furthermore, the integration of DeepSeek's AI technology, while a positive step towards enhancing medical services, may not have a direct impact on the company's financials in the near term.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

3. NewsRoom

Card image cap

Head to Head Review: Prosus (OTCMKTS:PROSY) versus Akso Health Group (NASDAQ:AHG)

Dec -01

Card image cap

AHG Utilizes DeepSeek to Advance AI in Healthcare

Feb -18

Card image cap

AHG Announces Plan to Acquire Online Clinic

Jan -31

Card image cap

The 36% return this week takes Akso Health Group's (NASDAQ:AHG) shareholders one-year gains to 271%

Jan -31

Card image cap

Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Oct -16

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.50%)

6. Segments

Medical Devices

Expected Growth: 8.5%

Increasing demand for innovative medical products, growing need for efficient healthcare solutions, and advancements in medical technology are expected to drive the growth of Akso Health Group's Medical Devices segment.

7. Detailed Products

AksoCare

AksoCare is a comprehensive healthcare management platform that provides personalized health and wellness services to individuals and families.

AksoMed

AksoMed is a telemedicine platform that connects patients with healthcare professionals remotely, providing convenient and accessible healthcare services.

AksoWell

AksoWell is a wellness and prevention platform that provides personalized health and wellness programs, including nutrition, fitness, and stress management.

AksoInsights

AksoInsights is a healthcare analytics platform that provides data-driven insights and predictive analytics for healthcare organizations.

AksoConnect

AksoConnect is a healthcare integration platform that enables seamless data exchange and integration between healthcare systems and applications.

8. Akso Health Group's Porter Forces

Forces Ranking

Threat Of Substitutes

Akso Health Group operates in a niche market with limited substitutes, reducing the threat of substitutes.

Bargaining Power Of Customers

Akso Health Group's customers have limited bargaining power due to the specialized nature of its services.

Bargaining Power Of Suppliers

Akso Health Group's suppliers have moderate bargaining power due to the availability of alternative suppliers.

Threat Of New Entrants

The healthcare industry is highly regulated, and new entrants may face significant barriers to entry, but Akso Health Group still faces a high threat from new entrants.

Intensity Of Rivalry

Akso Health Group operates in a competitive market, but the intensity of rivalry is mitigated by the company's specialized services and strong brand reputation.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 52.61%
Debt Cost 3.95%
Equity Weight 47.39%
Equity Cost 4.53%
WACC 4.22%
Leverage 111.01%

11. Quality Control: Akso Health Group passed 2 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
S&U

A-Score: 6.1/10

Value: 7.7

Growth: 5.6

Quality: 7.6

Yield: 8.8

Momentum: 3.5

Volatility: 3.7

1-Year Total Return ->

Stock-Card
Atlanticus

A-Score: 5.7/10

Value: 7.5

Growth: 8.6

Quality: 5.8

Yield: 0.0

Momentum: 8.5

Volatility: 3.7

1-Year Total Return ->

Stock-Card
World Acceptance

A-Score: 5.3/10

Value: 7.6

Growth: 5.3

Quality: 6.7

Yield: 0.0

Momentum: 8.5

Volatility: 3.7

1-Year Total Return ->

Stock-Card
Krungthai Card

A-Score: 5.0/10

Value: 3.8

Growth: 6.7

Quality: 6.5

Yield: 6.7

Momentum: 2.0

Volatility: 4.3

1-Year Total Return ->

Stock-Card
Nisun International

A-Score: 4.2/10

Value: 8.5

Growth: 3.9

Quality: 6.5

Yield: 0.0

Momentum: 1.0

Volatility: 5.3

1-Year Total Return ->

Stock-Card
Akso Health

A-Score: 3.0/10

Value: 3.3

Growth: 4.1

Quality: 1.8

Yield: 0.0

Momentum: 5.0

Volatility: 3.7

1-Year Total Return ->

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

1.39$

Current Price

1.39$

Potential

-0.00%

Expected Cash-Flows